A comparison study of NuvaRing^® with 30EE/150LNG COC during six cycles reveals that NuvaRing^® yields dramatically lower incidences of irregular bleeding in women using NuvaRing^®.

 

 

 

 

 

The good cycle control is probably achieved through NuvaRing^®'s continous hormone release from the ring.